ClinicalTrials.Veeva

Menu

Digital Intervention Postoperative Protocol

Oregon Health & Science University (OHSU) logo

Oregon Health & Science University (OHSU)

Status

Completed

Conditions

Surgery
Pain, Postoperative
Otolaryngologic Disorder

Treatments

Device: Fitbit
Device: Virtual Reality

Study type

Interventional

Funder types

Other

Identifiers

NCT04828109
00021902

Details and patient eligibility

About

Postoperative recovery after head and neck surgery is complex, and often requires utilization of narcotic medications. The aim of this study is to evaluate reduction in pain and use of opioid medications through Virtual Reality (VR) and Fitbit wearable activity devices.

Full description

Enhanced Recovery After Surgery (ERAS) protocols were introduced as a method to optimize perioperative patient care. Narcotic medications are frequently utilized in postoperative care, but these have risks including sedation or dependence. Non-pharmacologic measures for postoperative pain control may help limit the need for opioids in postoperative pain control.

Early mobilization is also important after surgery, however postoperative mobility is rarely monitored and relies on subjective reports.

The investigators will seek to examine the implementation of an ERAS protocol using VR and Fitbit wearable activity devices on postoperative recovery after head and neck surgery. This is a prospective, 4-arm, randomized controlled trial.

Enrollment

80 patients

Sex

All

Ages

18 to 89 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • English speaking
  • 18 to 89 years of age.
  • Planned to undergo major head and neck surgery OHSU with an expected length of stay of two days or more.
  • Ability to understand goals of the study and willingness to sign a written informed consent document.

Exclusion criteria

  • Planned postoperative admission to the intensive care unit (ICU).
  • Social or psychiatric conditions that may interfere with compliance.
  • Isolation precautions.
  • Reconstruction, incisions, wounds, wound care, or injury that impact the ability to place on the VR headset or wear a Fitbit device around the wrist.
  • History of seizure or epilepsy.
  • History of vertigo or persistent dizziness.
  • Limitations that impair mobility.
  • Use of a walker or wheelchair at baseline.

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

80 participants in 4 patient groups

VR and Fitbit
Active Comparator group
Description:
Daily VR use every 3 hours up to 30 minutes at a time and Fitbit daily step goal of 2,000 steps
Treatment:
Device: Fitbit
Device: Virtual Reality
VR Only
Active Comparator group
Description:
Daily VR only. Daily VR use every 3 hours up to 30 minutes at a time.
Treatment:
Device: Virtual Reality
Fitbit Only
Active Comparator group
Description:
Fitbit daily step goal of 2,000 steps.
Treatment:
Device: Fitbit
Control
No Intervention group
Description:
Standard of care

Trial contacts and locations

1

Loading...

Central trial contact

Vivek Pandrangi, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems